I would like to give my condolences to Bob Katsiouleris given the circumstances that appear to have caused his departure from ADN as MD & CEO. The extensive work he has done in re-focussing the core business for ADN has been the most important strategy for ADN to date. His immediate skills will be missed down the track but grateful for his consulting commitment to ADN.
I also would thank him for & I applaud his choice of Luke Anderson into the role of CEO & MD. ADN should not miss a beat going forward considering L A's background in the industry.
I find it disturbing that we have had posters here, denigrating BK & his reasons for stepping down. That response has been totally insensitive & inappropriate here and to those posters I would say "Have some respect."
Here, I would like to give my insincere thanks to the myriad of posters who may. inadvertantly, over a concerted amount of time, played some minor role in the reduction in the share price of ADN; The Harbs & his ilk, who have probably caused numerous shareholders to abandon ADN, to you I say thanks again as you have again enabled me to ADD more onto my (modest) pile of shares.
Hunter
- Forums
- ASX - By Stock
- ADN
- General comments/chat
General comments/chat, page-43375
Featured News
Add ADN (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.57M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.6¢ | $19.77K | 3.041M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
34 | 19595227 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 7890877 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
34 | 19595227 | 0.006 |
44 | 28815157 | 0.005 |
12 | 11398750 | 0.004 |
8 | 13134995 | 0.003 |
7 | 15650497 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 7890877 | 23 |
0.008 | 8368677 | 19 |
0.009 | 14861776 | 19 |
0.010 | 4800882 | 8 |
0.011 | 27266522 | 7 |
Last trade - 15.59pm 13/11/2024 (20 minute delay) ? |
Featured News
ADN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online